Shu-Chen Kuo

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

The Journal of antimicrobial chemotherapy

Microbiology spectrum

PloS one

Angewandte Chemie (International ed. in English)

National Health Research Institutes

National Yang Ming University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Health Research Institutes Aug 15 2011

Taiwan

Attending Physician

Education History

National Yang Ming University

Taiwan

PHD :: Institute of Clinical Medicine

Publications

Yi-Tsung Lin, Shu-Chen Kuo, Chi-Tai Fang, Tsai-Ling Lauderdale
Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020. Microbiology spectrum (2024)
Ya-Sung Yang, Hsing-Yu Chen, I Chieh Lin, Meng-He Lin, Wei-Yao Wang, Shu-Chen Kuo, Wen-Ting Chen, Yun-Hsiang Cheng, Jun-Ren Sun
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Pei-Jing Chen, Mei-Chen Tan, Wei-Cheng Huang, Shu-Yuan Hsu, Te-Li Chen, Chiou-Ying Yang, Shu-Chen Kuo
The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Pei-Jing Chen, Mei-Chen Tan, Wei-Cheng Huang, Shu-Yuan Hsu, Te-Li Chen, Chiou-Ying Yang, Shu-Chen Kuo
The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Yi-Tsung Lin, Shu-Chen Kuo, Chi-Tai Fang, Tsai-Ling Lauderdale
Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020. Microbiology spectrum 12 (8) (2024)
Pei-Jing Chen, Mei-Chen Tan, Wei-Cheng Huang, Shu-Yuan Hsu, Te-Li Chen, Chiou-Ying Yang, Shu-Chen Kuo
The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Ya-Sung Yang, Hsing-Yu Chen, I Chieh Lin, Meng-He Lin, Wei-Yao Wang, Shu-Chen Kuo, Wen-Ting Chen, Yun-Hsiang Cheng, Jun-Ren Sun
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species. The Journal of antimicrobial chemotherapy (2024)
Yi-Tsung Lin, Shu-Chen Kuo, Chi-Tai Fang, Tsai-Ling Lauderdale
Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020. Microbiology spectrum (2024)
Pei-Jing Chen, Mei-Chen Tan, Wei-Cheng Huang, Shu-Yuan Hsu, Te-Li Chen, Chiou-Ying Yang, Shu-Chen Kuo
The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis. The Journal of antimicrobial chemotherapy (2024)
Pei-Jing Chen, Mei-Chen Tan, Wei-Cheng Huang, Shu-Yuan Hsu, Te-Li Chen, Chiou-Ying Yang, Shu-Chen Kuo
The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Pei-Jing Chen, Mei-Chen Tan, Wei-Cheng Huang, Shu-Yuan Hsu, Te-Li Chen, Chiou-Ying Yang, Shu-Chen Kuo
The individual contributions of blaB, blaGOB and blaCME on MICs of β-lactams in Elizabethkingia anophelis. The Journal of antimicrobial chemotherapy 79 (7) (2024)
Mei-Chen Tan, Ying-Chi Huang, Pei-Jing Chen, Wei-Cheng Huang, Shu-Yuan Hsu, Hui-Ying Wang, Ci-Hong Liou, Jun-Ren Sun, Tsai-Ling Yang Lauderdale, Shu-Chen Kuo
In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species. The Journal of antimicrobial chemotherapy (2023)
Ya-Sung Yang, Hung-Jui Chen, Xiao-Chun Chen, Hung-Jen Tang, Fang-Ju Chang, Yun-Ling Huang, Yu-Ling Pan, Dinesh Kumar Kesavan, Huan-Yuan Chen, Hung-Sheng Shang, Shu-Chen Kuo, Te-Li Chen, Ming-Hsien Chiang
Elizabethkingia anophelis outer membrane vesicles as a novel vaccine candidate against infection: insights into immune response and potential for passive immunity. mSphere (2023)
Shu-Chen Kuo, Yung-Chih Wang, Mei-Chen Tan, Wei-Cheng Huang, Yih-Ru Shiau, Hui-Ying Wang, Jui-Fen Lai, I-Wen Huang, Tsai-Ling Lauderdale
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan. The Journal of antimicrobial chemotherapy 76 (8) (2021)
Fang-Hsuean Liao, Te-Haw Wu, Chun-Nien Yao, Shu-Chen Kuo, Chun-Jen Su, Yen-Ju Cheng, Shu-Yi Lin
A Supramolecular Trap to Increase the Antibacterial Activity of Colistin. Angewandte Chemie (International ed. in English) 59 (4) (2020)
Yung-Chih Wang, Shu-Man Shih, Yung-Tai Chen, Chao Agnes Hsiung, Shu-Chen Kuo
Clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan: a nationwide population-based retrospective cohort study. BMJ open 10 (11) (2020)
Feng-Jui Chen, Wei-Cheng Huang, Yu-Chieh Liao, Hui-Ying Wang, Jui-Fen Lai, Shu-Chen Kuo, Tsai-Ling Lauderdale, Huey-Kang Sytwu
Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014. Antimicrobial agents and chemotherapy 63 (4) (2019)
Yung-Tai Chen, Shu-Chen Kuo, Pei-Wen Chao, Yea-Yuan Chang
Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study. PloS one 14 (1) (2019)
Hao-Hsin Wu, Yea-Yuan Chang, Shu-Chen Kuo, Yung-Tai Chen
Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study. PloS one 14 (7) (2019)

Shu-Chen Kuo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shu-Chen Kuo